Rapid Development of Hypertension by Sorafenib: Toxicity or Target?

被引:46
作者
Humphreys, Benjamin D. [2 ,3 ]
Atkins, Michael B. [1 ,4 ]
机构
[1] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Lance Armstrong Fdn Adult Survivorship Program, Boston, MA 02115 USA
[4] Dana Farber Harvard Canc Ctr, Kidney Canc Program, Boston, MA USA
关键词
ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; CANCER;
D O I
10.1158/1078-0432.CCR-09-1717
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Blood pressure elevation is likely a pharmacodynamic marker of VEGF signaling pathway (VSP) inhibition and could be useful for optimizing safe and effective VSP inhibitor dosing. Blood pressure rises on the first day of treatment, facilitating design and interpretation of future trials aiming to correlate blood pressure changes with clinical outcomes. (Clin Cancer Res 2009;15(19):5947-9)
引用
收藏
页码:5947 / 5949
页数:3
相关论文
共 12 条
[1]   Effect of the Multitargeted Receptor Tyrosine Kinase Inhibitor, ABT-869 [N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N′-(2-fluoro-5-methylphenyl)urea], on Blood Pressure in Conscious Rats and Mice: Reversal with Antihypertensive Agents and Effect on Tumor Growth Inhibition [J].
Franklin, Pamela H. ;
Banfor, Patricia N. ;
Tapang, Paul ;
Segreti, Jason A. ;
Widomski, Deborah L. ;
Larson, Kelly J. ;
Noonan, William T. ;
Gintant, Gary A. ;
Davidsen, Steven K. ;
Albert, Daniel H. ;
Fryer, Ryan M. ;
Cox, Bryan F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (03) :928-937
[2]   Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability [J].
Fukumura, D ;
Gohongi, T ;
Kadambi, A ;
Izumi, Y ;
Ang, J ;
Yun, CO ;
Buerk, DG ;
Huang, PL ;
Jain, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2604-2609
[3]   Vascular endothelial growth factor vascular permeability factor produces nitric oxide-dependent hypotension - Evidence for a maintenance role in quiescent adult endothelium [J].
Horowitz, JR ;
Rivard, A ;
vanderZee, R ;
Hariawala, M ;
Sheriff, DD ;
Esakof, DD ;
Chaudhry, GM ;
Symes, JF ;
Isner, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2793-2800
[4]  
Kim JJ, 2009, J CLIN ONCOL, V27
[5]   Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib [J].
Lacouture, M. E. ;
Reilly, L. M. ;
Gerami, P. ;
Guitart, J. .
ANNALS OF ONCOLOGY, 2008, 19 (11) :1955-1961
[6]   Autocrine VEGF signaling is required for vascular homeostasis [J].
Lee, Sunyoung ;
Chen, Tom T. ;
Barber, Chad L. ;
Jordan, Maria C. ;
Murdock, Jared ;
Desai, Sharina ;
Ferrara, Napoleone ;
Nagy, Andras ;
Roos, Kenneth P. ;
Iruela-Arispe, M. Luisa .
CELL, 2007, 130 (04) :691-703
[7]   Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment [J].
Maitland, Michael L. ;
Kasza, Kristen E. ;
Karrison, Theodore ;
Moshier, Kristin ;
Sit, Laura ;
Black, Henry R. ;
Undevia, Samir D. ;
Stadler, Walter M. ;
Elliott, William J. ;
Ratain, Mark J. .
CLINICAL CANCER RESEARCH, 2009, 15 (19) :6250-6257
[8]   A Preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib [J].
Patel, Tejas V. ;
Morgan, Jeffrey A. ;
Demetri, George D. ;
George, Suzanne ;
Maki, Robert G. ;
Quigley, Michael ;
Humphreys, Benjamin D. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (04) :282-U12
[9]  
Rini BI, 2008, J CLIN ONCOL S, V26
[10]   Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100 [J].
Schneider, Bryan P. ;
Wang, Molin ;
Radovich, Milan ;
Sledge, George W. ;
Badve, Sunil ;
Thor, Ann ;
Flockhart, David A. ;
Hancock, Bradley ;
Davidson, Nancy ;
Gralow, Julie ;
Dickler, Maura ;
Perez, Edith A. ;
Cobleigh, Melody ;
Shenkier, Tamara ;
Edgerton, Susan ;
Miller, Kathy D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) :4672-4678